BioPerfectus Highlights Diagnostic Solutions for HPV & Cervical Cancer Screening, STIs and Vector-Borne Diseases
|
By LabMedica International staff writers Posted on 05 Feb 2024 |

Jiangsu Bioperfectus Technologies Co., Ltd. (Shanghai, China) is showcasing its range of diagnostics solutions for HPV and cervical cancer screening, sexually transmitted infections (STIs), and vector-borne diseases at Medlab Middle East 2024 that offer dependable, high-throughput, and cost-effective results.
BioPerfectus provides diagnostic solutions for STIs, including asymptomatic screening and clinical diagnosis. The key features of the company’s clinical STI testing technologies are adaptability and reliable outcomes. BioPerfectus’ products for STI asymptomatic screening, include the SAW-48 automated nucleic acid extraction workstation, the STC-96A PLUS Real-Time PCR system, nucleic acid extraction rapid kit, N. Gonorrhoeae / Chlamydia Trachomatis / U.urealyticum Real-Time PCR Kit, and STC auto interpretation software. In addition, BioPerfectus is highlighting its CE-marked PCR assays for STI clinical diagnostics such as Herpes Simplex Virus Real-Time PCR Kit, Herpes Simplex Virus Type I II Real-Time PCR Kit, Mycoplasma Genitalium Real-Time PCR Kit, Mycoplasma Hominis Real-Time PCR Kit, Trichomonas Vaginalis Real-Time PCR Kit and Treponema Pallidum Real-Time PCR Kit.
At Medlab Middle East 2024, BioPerfectus is showcasing its comprehensive range of diagnostic solutions essential for timely infectious disease control when outbreaks occur, including Vibrio Cholerae Real-Time PCR Kit, Monkeypox Virus Real-Time PCR Kit, Zika Virus / Dengue Virus / Chikungunya Virus Real-Time PCR Kit and Ebola Virus Real-Time PCR Kit. Visitors to the BioPerfectus booth at Medlab Middle East 2024 can experience the SAW-48 automated nucleic acid extraction workstation which is now lighter, smaller, and faster. Offering seamless workflow, it allows labs to go from the primary sample tube to a PCR ready-to-go tube in just one step, and say goodbye to time-consuming and complex processes.
Additionally, SAW-48 is compatible with various types of sample tubes and a diverse range of extraction and PCR reagents, making it the ideal choice for a wide spectrum of infectious disease diagnostic applications. In addition, BioPerfectus is highlighting the SSNP-2000B nucleic acid extraction system which integrates new technologies such as machine, electricity, and computer software to enable automatic nucleic acid extraction of 32 samples at one time. Alongside, BioPerfectus is presenting the STC-96A Plus Real-Time PCR system which is a more-than-ever flexible, efficient, and reliable breakthrough in the real-time PCR analysis of gene expression and genetic variation. It allows laboratories to apply two different PCR assays on just one instrument with separate controlled programs.
Related Links:
Jiangsu Bioperfectus Technologies Co., Ltd.
Latest Medlab 2024 News
- Anbio Biotechnology Presents Point-Of-Care IVD Solutions
- 77 Elektronika Showcases Latest Developments in Urinalysis
- BioVendor Group Unveils Latest Innovations in Immunodiagnostics and Molecular Diagnostics
- Sansure Presents Future of Pathogen Identification and Disease Diagnosis
- Spinreact Presents Latest Developments in IVD
- Alifax Demonstrates Automated Solutions to Improve Performance in Laboratory Settings
- YHLO Unveils New iBC 900 Automated Chemistry Analyzer
- Lifotronic Demonstrates Latest Medical Innovations in Disease Diagnostics
- Dymind Introduces New High-End Hematology Analyzer with Innovative Functions
- DIRUI Exhibits Latest Lab Automation Technologies and Devices
- Beckman Coulter Unveils DxC 500 AU Chemistry Analyzer
- Boule Presents Next Generation Hematology and Clinical Chemistry Systems
- bioMérieux Showcases Advanced Generation of VIDAS Immunoassay Solution
- Mindray Showcases Range of Advanced Total IVD Solutions
- Medlab Middle East 2024 Provides a Peek into the Laboratory of the Future
Channels
Clinical Chemistry
view channel
Mass Spectrometry Detects Tumor Metabolites for Cancer Monitoring
Cancer’s altered metabolism complicates how clinicians detect and monitor tumors, because nutrient use can shift with context and time. Measuring small-molecule metabolites that distinguish malignant from... Read more
Urinary Biomarker Assay Predicts Kidney Disease Progression Beyond Standard Measures
Many patients with type 2 diabetes and chronic kidney disease continue to experience progressive renal decline, yet conventional markers such as albuminuria and estimated glomerular filtration rate (eGFR)... Read moreMolecular Diagnostics
view channel
New Library Normalization and Amplification Tools Support Oncology Sequencing
High-throughput next-generation sequencing (NGS) laboratories continue to grapple with uneven library pooling and amplification artifacts that can degrade variant calling accuracy and increase reruns.... Read more
Statistical Method Improves Detection of Low-Level Cancer DNA in Blood Samples
Blood-based assays are increasingly used to detect and monitor cancer, but many require relatively high fractions of circulating tumor DNA, limiting their utility when disease burden is low.... Read moreHematology
view channel
Next-Generation Hematology Platform Streamlines High-Complexity Lab Workflows
Sysmex America (Chicago, IL, USA) has introduced the next generation XR-Series, centered on the XR-10 Automated Hematology Module for high-complexity laboratories. The platform builds on the widely used... Read more
Blood Eosinophil Count May Predict Cancer Immunotherapy Response and Toxicity
Immune checkpoint inhibitors have improved outcomes across many cancers, yet only a subset of patients derive durable benefit and biomarkers to guide treatment remain limited. Eosinophils, best known for... Read moreImmunology
view channelAptamer-Based Biosensor Enables Mutation-Resilient SARS-CoV-2 Detection
Rapid evolution of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) can undermine existing molecular diagnostics, especially when assays target small viral components. Double-antibody sandwich... Read more
Study Points to Autoimmune Pathway Behind Long COVID Symptoms
Long COVID leaves many SARS-CoV-2 survivors with persistent fatigue, cognitive issues, palpitations, and musculoskeletal pain for months or years. Estimates cited in new research suggest 4%–20% of infected... Read more
Metabolic Biomarker Distinguishes Latent from Active Tuberculosis and Tracks Treatment Response
Tuberculosis (TB) remains the world’s leading infectious killer, with 10.8 million cases and 1.25 million deaths recorded globally in 2023. Yet many infected individuals never develop active disease, underscoring... Read moreMicrobiology
view channel
TORCH Infection Trends Point to Need for Tailored Screening in Pregnancy
Congenital TORCH infections can be asymptomatic during pregnancy yet cause stillbirth, birth defects, and lifelong disability in infants. Many regions still lack robust surveillance to guide testing and... Read more
New Culture Medium Speeds C. difficile Resistance Detection and Reduces Costs
Clostridioides difficile infections remain a persistent threat in hospitals and communities, affecting about 500,000 people in the United States each year. Severe cases can be fatal within 30 days of diagnosis,... Read morePathology
view channel
AI Tool Speeds Brain Tumor Classification from Routine Histology Slides
Accurate classification of brain and spinal cord tumors increasingly depends on molecular profiling alongside histology, but access to such testing remains limited and results can take about two weeks.... Read more
IHC Companion Diagnostic Standardizes Mismatch Repair Testing for Cancer Immunotherapy
Deficient DNA mismatch repair is an established predictive biomarker for response to immune checkpoint inhibitors, yet access to standardized assessment has varied across tumor types. Cancer remains the... Read moreTechnology
view channel
AI Platform Links Biomarker Results to Cancer Clinical Trials and Guidelines
Oncology teams must manage growing volumes of genomic data, rapidly evolving clinical trial options, and frequently updated care guidelines, all within tight clinic schedules. Translating complex tumor... Read more
Agentic AI Platform Supports Genomic Decision-Making in Oncology
Oncology care teams increasingly face the challenge of managing complex molecular diagnostics, evolving treatment options, and extensive electronic health record documentation. Translating multimodal data... Read moreIndustry
view channel
Open-Source Consortium Aims to Standardize Digital Pathology Workflows
Digital pathology is expanding rapidly as laboratories adopt whole-slide imaging and computational tools to meet growing diagnostic and biomarker-testing demand. However, fragmented software infrastructure... Read more









